Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial

Fig. 1

Patient enrolment and randomization. One patient in arm A received only 1 Auxora dose due to rapid improvement and early discharge, and 1 patient in arm B refused the third dose of Auxora. One patient in arm B, who received all 3 doses, was transferred after 120 h to another institution. In the standard of care group of arm A, 1 patient withdrew from the study at 96 h after being made do not intubate (DNI) because of declining respiratory status

Back to article page
\